Search Results - "Litviakov, Nikolay V"

GLCE rs3865014 (Val597Ile) polymorphism is associated with breast cancer susceptibility and triple-negative breast cancer in Siberian population by Belyavskaya, Valentina A., Prudnikova, Tatiana Y., Domanitskaya, Natalya V., Litviakov, Nikolay V., Maksimov, Vladimir N., Cherdyntseva, Nadezhda V., Grigorieva, Elvira V.

“…d-Glucuronyl C5-epimerase (GLCE) is one of key enzymes in heparan sulfate biosynthesis and possesses tumour-suppressor function in breast carcinogenesis. Here,…”
Get full text

Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression by Denisov, Evgeny V., Litviakov, Nikolay V., Zavyalova, Marina V., Perelmuter, Vladimir M., Vtorushin, Sergey V., Tsyganov, Matvey M., Gerashchenko, Tatiana S., Garbukov, Evgeny Yu, Slonimskaya, Elena M., Cherdyntseva, Nadezhda V.

“…In this study, the influence of intratumoral morphological heterogeneity of breast cancer on neoadjuvant chemotherapy (NAC) efficiency was investigated. In…”
Get full text

Phenotypic drift as a cause for intratumoral morphological heterogeneity of invasive ductal breast carcinoma not otherwise specified by Zavyalova, Marina V, Denisov, Evgeny V, Tashireva, Lubov A, Gerashchenko, Tatiana S, Litviakov, Nikolay V, Skryabin, Nikolay A, Vtorushin, Sergey V, Telegina, Nadezhda S, Slonimskaya, Elena M, Cherdyntseva, Nadezhda V, Perelmuter, Vladimir M

“…Invasive ductal carcinoma (IDC) not otherwise specified (NOS), the most common type of breast cancer, demonstrates great intratumoral morphological…”
Get full text

CNA Landscape of HER2-Negative Breast Cancer in Anthracycline-Based Neoadjuvant Chemotherapy Regimens by Ibragimova, M K, Kravtsova, E A, Tsyganov, M M, Litviakov, N V

“…Critical evaluation of how and when to include anthracyclines in preoperative chemotherapy is becoming more relevant in an era when the molecular genetic…”
Get full text

LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER by Tsyganov, M. M., Ibragimova, M. K., Pevzner, A. M., Litviakov, N. V.

“…One of the factors of variability of malignant neoplasms is the loss of heterozygosity (LOH). The biological meaning of LOH, in relation to carcinogenesis, is…”
Get full text